Posted in | News

New Guide for Global Homebuilding Industry

Research and Markets has announced the addition of the "Homebuilding: Global Industry Guide" report to their offering.

Homebuilding: Global Industry Guide is an essential resource for top-level data and analysis covering the Homebuilding industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Highlights

The global homebuilding industry shrank by 3.1% in 2011 to reach a value of $6,146.6 billion.

In 2016, the global homebuilding industry is forecast to have a value of $12,989 billion, an increase of 111.3% since 2011.

The global homebuilding industry shrank by 6.6% in 2011 to reach a volume of 27,057,423.4 housing units.

In 2016, the global homebuilding industry is forecast to have a volume of 46,306,606.7 housing units, an increase of 71.1% since 2011.

Asia-Pacific accounts for 77.3% of the global homebuilding industry value.

Companies Mentioned:

  • Bouygues S.A.
  • Kajima Corporation
  • Obayashi Corporation
  • Shimizu Corporation
  • Taisei Corporation
  • Eiffage SA
  • Bilfinger Berger SE
  • HOCHTIEF AG
  • Strabag SE
  • Uni Land SPA
  • Koninklijke BAM Groep nv
  • Mattamy Homes
  • PCL Constructors Inc.
  • PulteGroup, Inc
  • Bellway plc
  • Bellway plc: key financial ratio
  • Shenzhen Investment Limited
  • Sun Hung Kai Properties Limited
  • Ballast Nedam NV
  • Ballast Nedam NV: key financial ratio
  • Heijmans NV
  • Royal Volker Wessels Stevin NV
  • Ferrovial, S.A.
  • Fomento de Construcciones y Contratas S.A.
  • Persimmon PLC
  • Taylor Wimpey PLC
  • D.R. Horton, Inc
  • Lennar Corporation
  • NVR, Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.